PhD Candidate: Translational CAR‑T for Pediatric Tumors

Unist; Madrid; Presencial; EUR 26.000 - 30.000; A tiempo parcial

Descripción de la vacante

Autonomous University of Madrid seeks a PhD candidate to join a translational project focused on CAR‑T therapies for pediatric CNS tumors, including rhabdoid tumors. You will work in a multidisciplinary team spanning molecular biology, immunology, and clinical hemato‑oncology, contributing to data generation, analysis, and interpretation of findings in line with current literature.

The role combines extensive in‑vitro culture with patient-derived samples and in‑vivo murine validation to assess

Formación

• University degree in Biology, Biomedicine, Biotechnology, Pharmacy, Medicine, or related life sciences discipline.
• Solid theoretical background in cellular immunology and/or cancer biology; interest in cell/gene therapy approaches.
• Practical experience in cell culture and basic molecular biology methods (e.g., flow cytometry, cytotoxicity assays).
• Willingness to work with laboratory animals (murine models).
• Motivation to participate in outreach and public engagement activities.

Responsabilidades

• Design, development, and preclinical validation of CAR‑T cell therapies targeting pediatric CNS tumors (rhaboid/AT/RT).
• Lead data generation, analysis, and interpretation in context of current literature.
• Perform in‑vitro cell culture experiments with patient-derived samples and in‑vivo validation in murine models.

Conocimientos

Biology/Biomedicine background

Immunotherapy interest

Cell culture experience

Flow cytometry

Molecular biology techniques

English proficiency

Team collaboration

Outreach and public engagement

Educación

Biology/Biomedicine/Pharmacy degree

Herramientas

Flow cytometry

Lentiviral vector production

Lentiviral transduction

Descripción del empleo

Autonomous University of Madrid seeks a PhD candidate to join a translational project focused on CAR‑T therapies for pediatric CNS tumors, including rhabdoid tumors. You will work in a multidisciplinary team spanning molecular biology, immunology, and clinical hemato‑oncology, contributing to data generation, analysis, and interpretation of findings in line with current literature.

The role combines extensive in‑vitro culture with patient-derived samples and in‑vivo murine validation to assess